CAPR · Capricor Therapeutics, Inc.

$19.50 +0.06 (+0.31%) At close · Jul 20

Market Cap

$1.15B

57.91M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Anthony "A.J." Bergmann	CFO	$287,500	$27,500	—	$475,692	—	$1,500	$792,192
Karen G. Krasney	General Counsel	$313,750	$31,500	—	$415,855	—	$1,500	$762,605

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Karen G. Krasney	General Counsel	$300,000	—	—	$38,827	—	$1,500	$340,327
Anthony "A.J." Bergmann	CFO	$212,500	—	—	$38,827	—	$1,500	$252,827

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Karen G. Krasney	General Counsel	$300,000	—	—	$50,890	—	$1,000	$351,890
Anthony "A.J." Bergmann	CFO	$200,000	—	—	$72,700	—	$1,000	$273,700

Key facts CIK 1133869 CUSIP 14070B309 13F (30d) 9 filings 9 filers Visit website Investor relations